High at 75. Is a lean as downtown and airport broke the previous record. Here in the bay area it was plenty warm around half machine bay. 72 degrees 67 oak land. 63 santa rosa. San jose moffitt field out towards livermore. Heres live view from the east bay hills camera where the sky hills camera where the skies are clear but the air quality continues to suffer. Tomorrow is another spare the air day. Poor air quality for most of the bay area. Moderate for the South Central bay. Let you know when you can expect an improvement in the air quality coming right up. Amma. All right thank you so much sandhya. Well if you spend any time outside today you likely notice the haze that sandhya was talking about. 7 News Reporter vick lee tells you what is needed to finally clear out the air. The air seems like it is fresh and clean. But its not. Just ask amber she moved to idaho 6 months ago. I came back i was extremely surprised by how the cloud of pollution you can see coming into the area. Its pr
Chips to Technology Stocks grabbed investors attention. All that and more tonight on nightly Business Report for monday, april 28th. Good evening, everyone. 100 billion. Thats what pfizer is offering to pay for astrazeneca. This is the Second Time Around pfizer is pushing for a deal with its british rival. Investors are cheering. Sending the dow soaring. Shares of pfizer shot up more than 4 by far the biggest gainer in the dow and astrazeneca jumped 12 . While the pharmaceutical deal may be huge its not a done deal. Astrazeneca has already rejected the offer and an earlier approach from pfizer saying the 100 billion cash and stock offer is too low and that it undervalues the company. We took a look at what combining these two companies mean to the pharmaceutical industry and whats at stake for pfizer and astrazeneca. Its the kind of deal that doesnt come around too often. 14 years ago pfizer paid 85 billion to buy warner lambert. That was the Biggest Health care combination ever. And s
Chips to Technology Stocks grabbed investors attention. All that and more tonight on nightly Business Report for monday, april 28th. Good evening, everyone. 100 billion. Thats what pfizer is offering to pay for astrazeneca. This is the Second Time Around pfizer is pushing for a deal with its british rival. Investors are cheering. Sending the dow soaring. Shares of pfizer shot up more than 4 by far the biggest gainer in the dow and astrazeneca jumped 12 . While the pharmaceutical deal may be huge its not a done deal. Astrazeneca has already rejected the offer and an earlier approach from pfizer saying the 100 billion cash and stock offer is too low and that it undervalues the company. We took a look at what combining these two companies mean to the pharmaceutical industry and whats at stake for pfizer and astrazeneca. Its the kind of deal that doesnt come around too often. 14 years ago pfizer paid 85 billion to buy warner lambert. That was the Biggest Health care combination ever. And s
Grabbed investors attention. All that and more tonight on nightly Business Report for monday, april 28th. Good evening, everyone. 100 billion. Thats what pfizer is offering to pay for astrazeneca. This is the Second Time Around pfizer is pushing for a deal with its british rival. Investors are cheering. Sending the dow soaring. Shares of pfizer shot up more than 4 by far the biggest gainer in the dow and astrazeneca jumped 12 . While the pharmaceutical deal may be huge its not a done deal. Astrazeneca has already rejected the offer and an earlier approach from pfizer saying the 100 billion cash and stock offer is too low and that it undervalues the company. We took a look at what combining these two companies mean to the pharmaceutical industry and whats at stake for pfizer and astrazeneca. Its the kind of deal that doesnt come around too often. 14 years ago pfizer paid 85 billion to buy warner lambert. That was the Biggest Health care combination ever. And since the recession theres b
Of millions and by this Time Next Year over a billion such doses of r. Available for anyone and everyone who needs it. The implications are all of this on a fastmoving day with dr. Shah nanna internal medical physician. So good to have you. Thank you for taking the time. Let me ask you about the significance of this and what do we make about this case modernas offering . Neil, the preliminary findings out today from moderna are quite promising. Having two potentially viable vaccine candidates is good news. Both pfizer and mow concern naps vaccines seem to have both similar efficacy profiles. Both rna vaccines and two dose regimens given a few weeks apart. Moderna has a significant practical advantage over pfizer kept undermine news degree celsius widely used freezer that most doctors offices and farmer is is already have but in all likelihood will need both given the dosage needs in order to vaccinate many millions of people. Right now they are gathering safety data and next step to fi